Miralax and Mylicon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Miralax (polyethylene glycol 3350) and Mylicon (simethicone). Common drug interactions include renal failure among females and ascites among males.

The phase IV clinical study analyzes what interactions people have when they take Miralax and Mylicon. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

What is Mylicon?

Mylicon has active ingredients of simethicone. eHealthMe is studying from 218 Mylicon users. Check the latest studies of Mylicon.

On Aug, 08, 2026

13 people who take Miralax and Mylicon together, and have interactions are studied.

What are the common drug interactions of Miralax and Mylicon, by gender? *:

female:

Renal failure (kidney dysfunction)
Abdominal discomfort
Acute respiratory distress syndrome
Anaemia (lack of blood)
Anoxia (low oxygen)
Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Bradycardia (abnormally slow heart action)
Brain injury
Budd-chiari syndrome (problem that results from blood clotting in the veins flowing out of the liver (hepatic veins))

male:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Empyema (collection of pus in a cavity in the body)
Infectious pleural effusion (infectious fluid in the lung)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Adverse event
Haemoglobin decreased
Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)
Pneumonia

What are the common drug interactions of Miralax and Mylicon, by age (0-1 to 60+)? *:

0-1:

Acute respiratory distress syndrome
Anoxia (low oxygen)
Bradycardia (abnormally slow heart action)
Brain injury
Cardiac arrest
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Cerebral disorder (brain disease)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Diabetes mellitus inadequate control

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Haemorrhoidal haemorrhage (bleeding from the haemorrhoids)

40-49:

Anaemia (lack of blood)
Presyncope

50-59:

n/a

60+:

Ascites (accumulation of fluid in the abdominal cavity)
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Empyema (collection of pus in a cavity in the body)
Infectious pleural effusion (infectious fluid in the lung)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Abdominal discomfort
Adverse event
Cough
Haemoglobin decreased

What are the existing conditions these people have? *

Pain: 5 people, 38.46%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 30.77%
Fever: 2 people, 15.38%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Stress And Anxiety: 1 person, 7.69%
Depression: 1 person, 7.69%
Empyema (collection of pus in a cavity in the body): 1 person, 7.69%
Embolism Venous (embolus may pass into the arterial system): 1 person, 7.69%
Dyspnea (difficult or laboured breathing): 1 person, 7.69%
Dyslipidaemia (abnormal amount of lipids): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Miralax and Mylicon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously